Clopidogrel besylate

苯磺酸氯吡格雷

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameClopidogrel besylate
Drug Alias NameClopidogrel besilateLoracle
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 agonists
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsThromboembolism
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2010/08/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeB01AC04
Related LinksKEGG